Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer.
about
Advances in the Development of Molecularly Targeted Agents in Non-Small-Cell Lung Cancer.Dosing immunotherapy combinations: Analysis of 3,526 patients for toxicity and response patterns.Tackling Cancer Resistance by Immunotherapy: Updated Clinical Impact and Safety of PD-1/PD-L1 Inhibitors.Overexpression of adhesion molecules and barrier molecules is associated with differential infiltration of immune cells in non-small cell lung cancer.Programmed death-ligand 1 testing in patients with non-small cell lung cancer: Ready for prime time?A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus).Combining immunotherapy with radiation therapy in thoracic oncology
P2860
Q39220897-11091005-4B1E-44F1-82BC-ED9271242232Q44209463-FB96CE51-49A8-482F-92D1-810897C380B7Q47712161-FF045E24-9FC6-4DB7-9863-592B16622B46Q49166013-DD6675DF-55B0-49B4-9CC3-E7890D38944DQ50581693-02188411-0EB1-419F-8DF9-9A30C26DA5C5Q50956087-5F673283-23BE-42EF-9B16-5FDD8366F2DCQ58804834-CEE4837B-17A9-43A6-9B47-858BA11B9F2A
P2860
Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer.
@en
type
label
Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer.
@en
prefLabel
Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer.
@en
P2093
P2860
P1433
P1476
Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer.
@en
P2093
Benjamin Herzberg
Justin F Gainor
Meghan J Campo
P2860
P356
10.1634/THEONCOLOGIST.2016-0189
P577
2016-08-17T00:00:00Z